Oxidized LDL/β2-glycoprotein I complexes: New aspects in atherosclerosis

Eiji Matsuura, Kazuko Kobayashi, K. Inoue, L. R. Lopez, Y. Shoenfeld

Research output: Contribution to journalArticle

55 Citations (Scopus)

Abstract

β2-glycoprotein I (β2GPI) is a major antigenic target for antiphospholipid antibodies. Oxidized low-density lipoprotein (oxLDL) is the principal lipoprotein found in atherosclerotic lesions, and it colocalizes with β2GPI and immunoreactive lymphocytes. oxLDL/β2GPI complexes appeared in the blood circulation of patients with diseases, such as systemic lupus erythematosus (SLE), antiphospholipid syndrome (APS), systemic sclerosis, diabetes mellitus and chronic renal diseases. Thus, the complexes may be associated with systemic and chronic inflammation of the vasculature. IgG anti- oxLDL/β2GPI complexes autoantibodies and their immune complexes were detected only in SLE/APS patients and in its animal model and were strongly associated with arterial thrombosis. The oxLDL/β2GPI complexes were internalized by macrophages via IgG anti-β2GPI antibody-mediated phagocytosis. In contrast, IgM anti-oxLDL antibodies derived from hyperlipidemic mice reduced the incidence of atherosclerosis. The distribution patterns of IgG and IgM anti-oxLDL antibodies in patients suggest the different roles of these antibodies.

Original languageEnglish
Pages (from-to)736-741
Number of pages6
JournalLupus
Volume14
Issue number9
DOIs
Publication statusPublished - 2005

Fingerprint

LDL Lipoproteins
Atherosclerosis
Glycoproteins
Antiphospholipid Syndrome
Antibodies
Systemic Lupus Erythematosus
Antiphospholipid Antibodies
Blood Circulation
Systemic Scleroderma
Antigen-Antibody Complex
Chronic Renal Insufficiency
Phagocytosis
Autoantibodies
Lipoproteins
oxidized low density lipoprotein
Diabetes Mellitus
Thrombosis
Animal Models
Macrophages
Lymphocytes

Keywords

  • β-glycoprotein I (βGPI)
  • Antiphospholipid syndrome (APS)
  • Atherosclerosis
  • Autoantibody
  • Oxidized low-density lipoprotein (oxLDL)

ASJC Scopus subject areas

  • Rheumatology
  • Immunology

Cite this

Oxidized LDL/β2-glycoprotein I complexes : New aspects in atherosclerosis. / Matsuura, Eiji; Kobayashi, Kazuko; Inoue, K.; Lopez, L. R.; Shoenfeld, Y.

In: Lupus, Vol. 14, No. 9, 2005, p. 736-741.

Research output: Contribution to journalArticle

Matsuura, Eiji ; Kobayashi, Kazuko ; Inoue, K. ; Lopez, L. R. ; Shoenfeld, Y. / Oxidized LDL/β2-glycoprotein I complexes : New aspects in atherosclerosis. In: Lupus. 2005 ; Vol. 14, No. 9. pp. 736-741.
@article{cc810c89ce7a498b8b81e516715b135b,
title = "Oxidized LDL/β2-glycoprotein I complexes: New aspects in atherosclerosis",
abstract = "β2-glycoprotein I (β2GPI) is a major antigenic target for antiphospholipid antibodies. Oxidized low-density lipoprotein (oxLDL) is the principal lipoprotein found in atherosclerotic lesions, and it colocalizes with β2GPI and immunoreactive lymphocytes. oxLDL/β2GPI complexes appeared in the blood circulation of patients with diseases, such as systemic lupus erythematosus (SLE), antiphospholipid syndrome (APS), systemic sclerosis, diabetes mellitus and chronic renal diseases. Thus, the complexes may be associated with systemic and chronic inflammation of the vasculature. IgG anti- oxLDL/β2GPI complexes autoantibodies and their immune complexes were detected only in SLE/APS patients and in its animal model and were strongly associated with arterial thrombosis. The oxLDL/β2GPI complexes were internalized by macrophages via IgG anti-β2GPI antibody-mediated phagocytosis. In contrast, IgM anti-oxLDL antibodies derived from hyperlipidemic mice reduced the incidence of atherosclerosis. The distribution patterns of IgG and IgM anti-oxLDL antibodies in patients suggest the different roles of these antibodies.",
keywords = "β-glycoprotein I (βGPI), Antiphospholipid syndrome (APS), Atherosclerosis, Autoantibody, Oxidized low-density lipoprotein (oxLDL)",
author = "Eiji Matsuura and Kazuko Kobayashi and K. Inoue and Lopez, {L. R.} and Y. Shoenfeld",
year = "2005",
doi = "10.1191/0961203305lu2211oa",
language = "English",
volume = "14",
pages = "736--741",
journal = "Lupus",
issn = "0961-2033",
publisher = "SAGE Publications Ltd",
number = "9",

}

TY - JOUR

T1 - Oxidized LDL/β2-glycoprotein I complexes

T2 - New aspects in atherosclerosis

AU - Matsuura, Eiji

AU - Kobayashi, Kazuko

AU - Inoue, K.

AU - Lopez, L. R.

AU - Shoenfeld, Y.

PY - 2005

Y1 - 2005

N2 - β2-glycoprotein I (β2GPI) is a major antigenic target for antiphospholipid antibodies. Oxidized low-density lipoprotein (oxLDL) is the principal lipoprotein found in atherosclerotic lesions, and it colocalizes with β2GPI and immunoreactive lymphocytes. oxLDL/β2GPI complexes appeared in the blood circulation of patients with diseases, such as systemic lupus erythematosus (SLE), antiphospholipid syndrome (APS), systemic sclerosis, diabetes mellitus and chronic renal diseases. Thus, the complexes may be associated with systemic and chronic inflammation of the vasculature. IgG anti- oxLDL/β2GPI complexes autoantibodies and their immune complexes were detected only in SLE/APS patients and in its animal model and were strongly associated with arterial thrombosis. The oxLDL/β2GPI complexes were internalized by macrophages via IgG anti-β2GPI antibody-mediated phagocytosis. In contrast, IgM anti-oxLDL antibodies derived from hyperlipidemic mice reduced the incidence of atherosclerosis. The distribution patterns of IgG and IgM anti-oxLDL antibodies in patients suggest the different roles of these antibodies.

AB - β2-glycoprotein I (β2GPI) is a major antigenic target for antiphospholipid antibodies. Oxidized low-density lipoprotein (oxLDL) is the principal lipoprotein found in atherosclerotic lesions, and it colocalizes with β2GPI and immunoreactive lymphocytes. oxLDL/β2GPI complexes appeared in the blood circulation of patients with diseases, such as systemic lupus erythematosus (SLE), antiphospholipid syndrome (APS), systemic sclerosis, diabetes mellitus and chronic renal diseases. Thus, the complexes may be associated with systemic and chronic inflammation of the vasculature. IgG anti- oxLDL/β2GPI complexes autoantibodies and their immune complexes were detected only in SLE/APS patients and in its animal model and were strongly associated with arterial thrombosis. The oxLDL/β2GPI complexes were internalized by macrophages via IgG anti-β2GPI antibody-mediated phagocytosis. In contrast, IgM anti-oxLDL antibodies derived from hyperlipidemic mice reduced the incidence of atherosclerosis. The distribution patterns of IgG and IgM anti-oxLDL antibodies in patients suggest the different roles of these antibodies.

KW - β-glycoprotein I (βGPI)

KW - Antiphospholipid syndrome (APS)

KW - Atherosclerosis

KW - Autoantibody

KW - Oxidized low-density lipoprotein (oxLDL)

UR - http://www.scopus.com/inward/record.url?scp=26244454758&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=26244454758&partnerID=8YFLogxK

U2 - 10.1191/0961203305lu2211oa

DO - 10.1191/0961203305lu2211oa

M3 - Article

C2 - 16218478

AN - SCOPUS:26244454758

VL - 14

SP - 736

EP - 741

JO - Lupus

JF - Lupus

SN - 0961-2033

IS - 9

ER -